JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 3, 2007; DOI: 10.1124/jpet.107.124271


0022-3565/07/3231-174-179$20.00
JPET 323:174-179, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.124271v1
323/1/174    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LePage, K. T.
Right arrow Articles by Murray, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LePage, K. T.
Right arrow Articles by Murray, T. F.

TOXICOLOGY

Gambierol Acts as a Functional Antagonist of Neurotoxin Site 5 on Voltage-Gated Sodium Channels in Cerebellar Granule Neurons

K. T. LePage, J. D. Rainier, H. W. B. Johnson, D. G. Baden, and T. F. Murray

Department of Biology, Xavier University of Louisiana, New Orleans, Louisiana (K.T.L.); Department of Chemistry, University of Utah, Salt Lake City, Utah (J.D.R., H.W.B.J.); Center for Marine Science, University of North Carolina at Wilmington, Wilmington, North Carolina (D.G.B.); and Department of Pharmacology, School of Medicine, Creighton University, Omaha, Nebraska (T.F.M.)

Received for publication April 11, 2007
Accepted June 26, 2007.


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
The marine toxin gambierol, a polyether ladder toxin derived from the marine dinoflagellate Gambierdiscus toxicus, was evaluated for interaction with voltage-gated sodium channels (VGSCs) in cerebellar granule neuron (CGN) cultures. At concentrations ranging from 10 nM to 10 µM, gambierol alone had no effect on the intracellular Ca2+ concentration [Ca2+]i of exposed CGN cultures. Furthermore, there was no evidence of neurotoxicity in CGN cultures exposed for 2 h to gambierol (1 nM–10 µM). However, gambierol was a potent inhibitor (IC50 = 189 nM) of the elevation of [Ca2+]i that accompanies exposure of CGN cultures to the VGSC activator brevetoxin-2 (PbTx-2). To further explore the potential interaction of gambierol with VGSCs, the influence of gambierol on PbTx-2-induced neurotoxicity was assessed. Gambierol reduced the PbTx-2-induced efflux of lactate dehydrogenase in exposed CGN cultures in a concentration-dependent manner (IC50 = 471 nM). It is noteworthy that the potencies of gambierol as an inhibitor of both PbTx-2-induced Ca2+ influx and cytotoxicity were coincident. Finally, the inhibitory effects of gambierol on PbTx-2-induced elevation of [Ca2+]i were compared with those of brevenal, a natural inhibitor of the toxic effects of brevetoxin isolated from cultures of Karina brevis. Like gambierol, brevenal inhibited PbTx-2-induced elevation of [Ca2+]i in a concentration-dependent manner (IC50 = 108.6 nM). These results provide evidence for gambierol acting as a functional antagonist of neurotoxin site 5 on neuronal VGSCs.


Gambierdiscus toxicus, a marine dinoflagellate, is the source of ciguatoxin (CTX) and gambierol, ladder-shaped polyethers composed of trans/syn-fused ether rings of variable sizes (Lewis, 2001Go). Ingestion of particular tropical and subtropical reef fish species can result in ciguatera, a form of human poisoning that is a major health concern in populations that derive a significant portion of their dietary protein from affected marine species. The structure of CTX is similar to that of brevetoxins (PbTx), which are potent voltage-gated sodium channel (VGSC)-specific toxins produced by the dinoflagellate Karina brevis (Baden and Adams, 2000Go; Lewis, 2001Go). CTX and PbTx are selective activators of VGSCs (Cestèle and Catterall, 2000Go). Six pharmacologically distinct neurotoxin binding sites are associated with VGSCs, with CTX and PbTx being activators of neurotoxin site 5 (Gawley et al., 1992Go; Gordon, 1997Go; Hogg et al., 1998Go; Dechraoui et al., 1999Go). Although both CTX and PbTx bind to neurotoxin site 5 on neuronal and cardiac VGSCs with high affinity, CTX is approximately 2 orders of magnitude more potent than PbTx-3 in activating neuronal VGSCs (Gawley et al., 1992Go, Jeglitsch et al., 1998Go; Dechraoui et al., 1999Go). Neurons exposed to CTX demonstrate gradual membrane depolarization and tonic action potential firing (Hogg et al., 1998Go). CTX evokes an increase in the open probability of single VGSCs and a shift in the activation voltage of VGSCs to more negative potentials (Hogg et al., 1998Go). Likewise, PbTx-3 shifts the activation potential of the VGSC to more negative values and inhibits inactivation of the VGSC (Jeglitsch et al., 1998Go). CTX, unlike PbTx, has also been shown to produce VGSC-dependent oscillations in neuronal membrane potential, suggesting that there are some differences in the mechanisms of action of CTX and PbTx-3 on the VGSC (Hogg et al., 2002Go).

Cultures of G. toxicus also produce gambierol, which contains a transfused octacyclic polyether core, 18 stereogenic centers, and a skipped triene (Satake et al., 1993Go; Morohashi et al., 1999Go; Johnson et al., 2006Go) (Fig. 1). Investigations into the pathological and pharmacological characteristics of gambierol have been facilitated by chemical synthesis of the compound (Fuwa et al., 2002Go, 2004Go; Kadota et al., 2003Go; Johnson et al., 2006Go). Pathological effects in several tissues have been reported in mice following systemic exposure to gambierol. Gambierol has been shown to be a potent toxin with a minimal lethal dose ranging from 50 to 80 µg/kg (i.p.) in mice (Fuwa et al., 2003Go, 2004Go; Ito et al., 2003Go). Primary pathological effects of gambierol in mice were noted in the lung, with secondary effects in the heart (Ito et al., 2003Go). Gambierol also induced hypersecretion and ulceration in the stomach (Ito et al., 2003Go). Gambierol has also been reported to elicit aberrant behavior consistent with a neurotoxic insult (Ito et al., 2003Go). However, there are no reports of pathological changes in gambierol-exposed rodent brains. Recent investigations have established that gambierol inhibits voltage-gated potassium currents in mouse taste cells (Ghiaroni et al., 2005Go). Based on the production of gambierol by G. toxicus and the described pathological sequelae, gambierol is thought to contribute to the symptoms of ciguatera (Ito et al., 2003Go).


Figure 1
View larger version (10K):
[in this window]
[in a new window]

 
Fig. 1. Structure of gambierol.

 
Bourdelais et al. (2004Go, 2005Go) have identified brevenal as another polyether ladder compound produced by K. brevis. Brevenal has been shown to competitively displace [3H]PbTx-3 from neurotoxin site 5 of the VGSC and to antagonize PbTx-induced bronchoconstriction in an animal model of asthma (Abraham et al., 2005Go; Bourdelais et al., 2005Go). Moreover, brevenal has been shown to be nontoxic to fish in a bioassay and to protect fish from the neurotoxic effects of brevetoxin exposure (Bourdelais et al., 2005Go).

Neurotoxin site 5 of the VGSC has been identified as the molecular target for both PbTx and CTX (Gawley et al., 1992Go; Baden and Adams, 2000Go). Inoue et al. (2003Go) demonstrated that gambierol inhibits the binding of [3H]PbTx-3 to VGSCs with a Ki value of 1.4 µM in synaptosomes derived from rat brains. These authors suggested that the ability of gambierol to inhibit the binding of [3H]PbTx-3 indicates that gambierol may also interact with neurotoxin site 5 (Inoue et al., 2003Go).

Herein, we take advantage of the recent synthesis of gambierol (Johnson et al., 2006Go) to extend the characterization of the toxin using functional responses in cerebellar granule neuron (CGN) cultures. Specifically, the effect of gambierol on VGSC activator (PbTx-2)-induced elevation of [Ca2+]i was examined. Gambierol interaction with the VGSC was further assessed by determining the ability of this compound to inhibit PbTx-2-induced neurotoxicity in intact neurons. Finally, we compared the effects of gambierol and brevenal as antagonists of PbTx-2-induced elevation of [Ca2+]i.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Cerebellar Granule Cell Culture. CGN cultures were harvested from 8-day-old Sprague-Dawley rats, and they were cultured as described by Berman and Murray (1996Go). Cells were plated onto poly-L-lysine (mol. wt. = 393,000)-coated 9-mm clear-bottomed black 96-well culture plates (Corning Life Sciences, Acton, MA) at a density of 9.6 x 104 cells/well and 12-well (Corning Life Sciences) culture dishes at 1.25 x 106 cells/well, respectively. Then, cells were incubated at 37°C in a 5% CO2 and 95% relative humidity atmosphere. CGN cultures at 8–13 days in culture (DIC) were used for lactate dehydrogenase efflux and Ca2+ influx studies.

Intracellular Ca2+ Monitoring. CGN cultures grown in 96-well plates were used for [Ca2+]i measurements at 10 to 13 DIC as described by Berman and Murray (2000Go). In brief, the growth media were removed, and they were replaced with a dye-loading medium (100 µl/well) containing 4 µM Fluo-3 (Invitrogen, Carlsbad, CA) and 0.04% Pluronic acid (Invitrogen) in Locke's buffer, pH 7.4. After 1-h incubation in a dye-loading medium, the neurons were washed four times in fresh Locke's buffer (200 µl/well) using an automated cell washer (Labsystems, Helsinki, Finland) and transferred to the fluorescence laser plate reader (FLIPR; Molecular Devices, Sunnyvale, CA) incubation chamber. The final volume of Locke's buffer in each well was 100 µl. Neurons were excited by the 488-nm line of the argon laser, and Ca2+-bound fluo-3 emission in the 500- to 600-nm range was recorded with a charge-coupled device camera with shutter speed set at 0.4 s. FLIPR operates by illuminating the bottom of a 96-well microplate with an argon laser and by measuring the emissions from cell-permeant dyes in all 96 wells simultaneously using a cooled charge-coupled device camera. Gambierol ([final] = 10 nM–10 µM) or brevenal ([final] = 0.1 nM–10 µM) was added to neurons from one source plate in a volume of 30 µl at the rate of 20 µl/s. Fluorescence readings were taken every 10 s for 1 min to establish a baseline. After incubation with gambierol, PbTx-2 ([final] = 20 nM) or Locke's buffer was added from another source plate as described previously. Fluorescence readings were taken every second for the first minute and every 8 s for the duration of the experiment (25 min). Background fluorescence was automatically subtracted from all Fluo-3 fluorescence measurements.

LDH Activity Assay. All assays were carried out in 1% dimethyl sulfoxide, which has no independent effect on these measures in CGN cultures (data not shown). Growth media were removed, and the cultures were washed two times in 1 ml of Locke's incubation buffer (154 mM NaCl, 5.6 mM KCl, 1 mM MgCl2, 2.3 mM CaCl2, 8.6 mM HEPES, 5.6 mM glucose, and 0.1 mM glycine, pH 7.4). CGN cultures were then exposed to gambierol (1 nM–10 µM) alone or in the presence of 40 nM PbTx-2 for 2 h at 22°C. At the termination of toxin exposure, exposure buffer was collected and assayed for LDH efflux. Cytotoxicity was assessed by quantifying the activity of LDH released by injured neurons into the exposure buffer at 2 h after the termination of toxin exposure. LDH activity was determined spectrophotometrically as described by Koh and Choi (1987Go). Data are reported as LDH activity units per well.

Preparation of Intact Synaptosomes. Rat synaptosomes were prepared using a modification of the protocol described by Dodd et al. (1981Go). In brief, adult female Sprague-Dawley rats were sacrificed, and the cortices were immediately dissected out over ice. The cortices were weighed, and then they were homogenized in 20 volumes of an ice-cold (4°C) 0.32 M sucrose buffer using a glass Dounce fitted with a loose Teflon pestle. The homogenate was centrifuged at 1000g at 4°C for 10 min. The supernatant was collected and centrifuged at 20,000g for 20 min. The resultant pellet was resuspended in an isotonic buffer (132 mM choline chloride and 25 mM Tris, pH 7.4), and then it was centrifuged at 20,000g for 20 min. The wash/centrifugation step was repeated, and the final pellet was resuspended in the isotonic buffer. The concentration of protein was determined using a modification of the method described by Lowry et al. (1951Go). The synaptosomes used in all binding assays were prepared on the day of the experiment.

[3H]PbTx-3 Equilibrium Competition Assay. The potency and efficacy of gambierol as a competitor of high-affinity [3H]PbTx-3 (PerkinElmer Life and Analytical Sciences, Boston, MA) binding to intact synaptosomes was evaluated via a centrifugation assay. In brief, increasing concentrations of gambierol (0.3 nM–30 µM) were incubated with [3H]PbTx-3 for 90 min in microcentrifuge tubes. The reactions were carried out in an isotonic buffer (132 mM choline chloride and 25 mM Tris, pH 7.4). Reactions were allowed to proceed for 3 h at 4°C. Assay tubes were then centrifuged at 21,000g for 2 min. The incubation buffer was aspirated, and the pellet was washed gently three times with ice-cold buffer. The pellet was placed into scintillation fluid, and it was agitated overnight to solubilize the pellet. The amount of [3H]PbTx-3 bound to the synaptosomal preparation was assessed by placing the samples in a scintillation counter (Beckman Coulter, Fullerton, CA).

Analysis of Experimental Data. Concentration-response data were analyzed by nonlinear least-square regression analysis with the GraphPad software suite, version 4.0 (GraphPad Software Inc., San Diego, CA) using a three-parameter logistic equation.

Reagents. Gambierol was synthesized as described by Johnson et al. (2006Go). This gambierol was purified by silica gel chromatography, and it was >95% pure by proton NMR. All reagents not mentioned in the text were obtained from Sigma-Aldrich (St. Louis, MO).


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Brevetoxin exposure produces a rapid elevation of [Ca2+]i that contributes to an acute necrotic cell death in CGN cultures (Fig. 2). As shown in Fig. 2, 20 nM PbTx-2 induced a robust elevation of [Ca2+]i in CGN cultures. Conversely, gambierol alone did not alter [Ca2+]i in CGN cultures during the 25-min exposure period (Fig. 2). Given this lack of activity of gambierol as an activator of neurotoxin site 5 on the VGSC, we evaluated the possibility that gambierol acts as an antagonist of this site. To this end, CGN cultures were exposed to 20 nM PbTx-2 in the absence and presence of various concentrations of gambierol. The results of these experiments depicted in Fig. 3 demonstrated that gambierol produced a concentration-dependent inhibition of PbTx-2-induced Ca2+ influx in CGN cultures. Nonlinear regression analysis of the concentration dependence of gambierol inhibition of the maximal PbTx-2-induced Ca2+ influx indicated that the IC50 value for gambierol was 189 nM (88.4–403.8 nM, 95% CI) (Fig. 4).


Figure 2
View larger version (21K):
[in this window]
[in a new window]

 
Fig. 2. Lack of effect of various concentrations of gambierol on Fluo-3 fluorescence in 10 to 13 DIC cerebellar granule neurons. Data depict means ± S.E.M. of a representative experiment performed in triplicate and repeated three times.

 

Figure 3
View larger version (27K):
[in this window]
[in a new window]

 
Fig. 3. Increases in Fluo-3 fluorescence produced by exposing 10 to 13 DIC cerebellar granule neurons to a submaximal concentration (20 nM) of PbTx-2 in the presence or absence of various concentrations of gambierol (GB). Data depict means ± S.E.M of a representative experiment performed in quintuplicate and repeated twice.

 

Figure 4
View larger version (16K):
[in this window]
[in a new window]

 
Fig. 4. Nonlinear regression analysis of gambierol antagonism of the maximal increment in Fluo-3 fluorescence evoked by 20 nM PbTx-2. Data depict pooled means from two experiments that were performed in quintuplicate. The IC50 value derived from this fit was 189 nM (88–404 nM, 95% CI).

 

In an effort to assess the specificity of gambierol antagonism of PbTx-2-induced Ca2+ influx, we assessed the ability of gambierol to block Ca2+ influx produced by a depolarizing concentration of KCl (50 mM) (Berman and Murray, 2000Go). We found that gambierol had no effect on the increase of intracellular Ca2+ in CGN cultures exposed to 50 mM KCl, indicating that gambierol does not block voltage-dependent Ca2+ channels (Fig. 5).


Figure 5
View larger version (21K):
[in this window]
[in a new window]

 
Fig. 5. Increases in Fluo-3 fluorescence produced by exposing 10 to 13 DIC cerebellar granule neurons to a depolarizing concentration (50 mM) of KCl in the presence or absence of various concentrations of gambierol. Data depict means ± S.E.M. of a representative experiment performed in quintuplicate and repeated twice.

 
Given the ability of gambierol to inhibit PbTx-2-induced Ca2+ influx in CGN cultures, we further assessed the potential for gambierol to protect CGN cultures from PbTx-2-induced excitotoxicity. In preliminary experiments, we established that a PbTx-2 concentration of 40 nM was sufficient to produce a robust neurotoxic response in CGN cultures. A 2-h exposure of CGN cultures to this challenge concentration of PbTx-2 resulted in significant neurotoxicity as reflected in the increase in LDH efflux into the culture medium (Fig. 6). Coincubation with gambierol produced a concentration-dependent reduction in PbTx-2-induced neurotoxicity, with the 10 µM concentration of gambierol eliminating the neurotoxic response. Nonlinear regression analysis of the concentration dependence of the gambierol reduction in PbTx-2-induced neurotoxicity indicated that the IC50 value for gambierol was 470.7 nM (164.9–1344.0 nM, 95% CI). This IC50 value did not differ significantly from that derived from the gambierol inhibition of PbTx-2-induced Ca2+ influx.


Figure 6
View larger version (14K):
[in this window]
[in a new window]

 
Fig. 6. Nonlinear regression analysis of gambierol antagonism of PbTx-2-induced neurotoxicity in cerebellar granule neurons. Neurons were exposed to PbTx-2 and/or gambierol for 2 h at room temperature. LDH efflux was then assessed as an indicator of cytotoxicity. Data depicted represent the means of two to three determinations. The IC50 value derived from this fit was 471 nM (165–1344 nM, 95% CI).

 

We further confirmed that gambierol inhibits the binding of [3H]PbTx-3 to VGSCs expressed on intact rat synaptosomes with a Ki value of 4.8 µM (2.5–9.4 µM, 95% CI) (Fig. 7). Our findings are consistent with the study of Inoue et al. (2003Go), who reported a Ki value of 1.4 µM for gambierol as a competitor of high-affinity [3H]PbTx-3 binding in rat synaptosomes. The current results support the contention that gambierol binds to neurotoxin site 5 of the VGSC.


Figure 7
View larger version (14K):
[in this window]
[in a new window]

 
Fig. 7. Inhibition of specific [3H]PbTx-3 binding by gambierol. Increasing concentrations of gambierol were added to intact rat synaptosomes. The concentration of [3H]PbTx-3 was 3 nM. The figure is derived from data from a representative experiment that was repeated twice in duplicate. Error bars represent ± S.E.M.

 
We also examined the ability of brevenal, a nontoxic antagonist of brevetoxin actions, to inhibit PbTx-2-induced elevation of [Ca2+]i in CGN cultures. As observed with gambierol, brevenal antagonized PbTx-2-induced elevation of [Ca2+]i in a concentration-dependent manner (IC50 = 108.6 nM; 49–240 nM, 95% CI) (Fig. 8).


Figure 8
View larger version (16K):
[in this window]
[in a new window]

 
Fig. 8. Nonlinear regression analysis of brevenal antagonism of the maximal total Fluo-3 fluorescence evoked by 20 nM PbTx-2. Data points represent the percentage of the total Ca2+ response of CGN cultures exposed to a 20 nM concentration of PbTx-2. Data from four independent cultures are depicted as mean values ± S.E.M.

 

    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Brevetoxins and the structurally related ciguatoxins represent a novel class of polyether ladder marine toxins that bind to the same recognition site on the {alpha} subunit of VGSCs (Gawley et al., 1992Go). The concordance of the rank order of potency brevetoxins and ciguatoxin in a mouse bioassay and in equilibrium competition binding using [3H]PbTx-3 to label neurotoxin site 5 on the VGSC suggests that the toxicity of these compounds is related to their binding to this VGSC site (Gawley et al., 1992Go). Gambierol has similarly been shown to bind to neurotoxin site 5 on the VGSC, albeit with modest affinity (IC50 = 1.4 µM) (Inoue et al., 2003Go).

Brevetoxins induce rapid neuronal depolarization by affecting both the activation- and inactivation-gating properties of VGSCs (Baden and Adams, 2000Go). Brevetoxin-induced autocrine excitotoxicity in cerebellar granule cells is associated with an evoked glutamate release, rapid influx of Ca2+, and a sustained Ca2+ load in exposed neurons (Berman and Murray, 2000Go). Excitotoxic responses to PbTx-1 are correlated with the magnitude of this Ca2+ load, although neuronal vulnerability is governed selectively by the N-methyl-D-aspartate receptor Ca2+ influx pathway that is indirectly activated indirectly by PbTx-1. In the present study, PbTx-2 elicited a rapid elevation in [Ca2+]i (Fig. 2). This Ca2+ influx is secondary to PbTx-2 activation of VGSCs, with subsequent activation of voltage-sensitive Ca2+ channels, the reverse mode of operation of the Na+/Ca2+ exchanger, and Ca2+ influx through N-methyl-D-aspartate receptors (Berman and Murray, 2000Go). We demonstrate here that gambierol acts as a functional antagonist of neurotoxin site 5 in that it effectively inhibits both PbTx-2-induced neurotoxicity and elevation of [Ca2+]i in CGN cultures. The mechanism by which gambierol acts as a PbTx-2 antagonist is unknown. The most parsimonious explanation is that gambierol binds to the VGSC at neurotoxin site 5 and acts as a competitive antagonist of PbTx-2 at this site. The finding that gambierol inhibits the specific binding of [3H]PbTx-3 is consistent with this suggestion. Alternatively, gambierol interaction with the VGSC may occlude the channel pore in a manner similar to that of tetrodotoxin or allosterically inhibit PbTx-2 interaction with neurotoxin site 5 (Cestèle and Catterall, 2000Go).

Gambierol differed from PbTx-2 in that, at concentrations ranging from 0.01 to 1.0 µM, it did not produce an influx of Ca2+ in CGNs. Inasmuch as we have previously shown that brevetoxin-induced Ca2+ influx is triggered by the activation of VGSCs, it is reasonable to infer that gambierol is not an activator of VGSC in CGNs. In contrast to these results, a recent report has found that gambierol produced a modest, relative to veratridine, increment in Ca2+ influx in neuroblastoma cells (Louzao et al., 2006Go). Based on the results of pharmacological experiments, these authors concluded that gambierol acts as a partial agonist at neurotoxin site 5 of the VGSC. However, the gambierol concentration-response curve for membrane depolarization in neuroblastoma cells was exponential with no defined maximum. Therefore, the EC50 value could not be determined, but it would be >30 µM, indicating that this response may be a nonspecific effect. In the absence of a demonstration of a tetrodotoxin- or saxitoxin-induced rightward shift of the gambierol concentration-response curve, the role of VGSCs in this response is uncertain. Louzao et al. (2006Go) reported that neosaxitoxin produced a very modest (15%) attenuation of gambierol-induced depolarization, but they did not provide a demonstration of antagonism of the gambierol-induced Ca2+ response. The absence of a positive allosteric coupling between gambierol and the neurotoxin site 2 activator veratridine in that report further indicates that the observed response to gambierol in neuroblastoma cells may not involve VGSCs. In addition, neuroblastoma cell lines may not provide sufficient sensitivity to this toxin, given their relatively low expression levels of VGSCs compared with neurons (LePage et al., 2005Go).

All natural brevetoxins are thought to bind to neurotoxin site 5 in a "head-down" orientation into the channel, intercalating with {alpha}-helices of domains III and IV of the VGSC (Poli et al., 1986Go; Gawley et al., 1995Go). Four distinct effects of brevetoxins on the VGSC have been elucidated, and they include a shift of the activation potential to more negative values, a prolongation of mean open time, an inhibition of channel inactivation, and the induction of multiple subconductance states (Jeglitsch et al., 1998Go). These alterations in sodium channel function promote the depolarization of neurons at resting membrane potential; thus, they account for the acute central and peripheral effects of brevetoxins observed in vivo. Gambierol is composed of eight fused polyether rings, and it is smaller than ciguatoxins or brevetoxins (11–13 rings) (Lewis, 2001Go; Yasumoto, 2001Go; Baden et al., 2005Go; Johnson et al., 2006Go). The truncated size of gambierol is similar to that of brevenal, a recently described component of K. brevis cultures that acts as an antagonist of PbTx-induced toxic effects (Bourdelais et al., 2004Go). Bourdelais et al. (2004Go) demonstrated that brevenal displaced [3H]PbTx-3 binding to brain synaptosomes, with a Ki value of 685 nM; moreover, it seemed to protect fish from PbTx-2- or PbTx-3-induced lethality. We have demonstrated a brevenal concentration-dependent antagonism of PbTx-2-induced Ca2+ influx in CGN cultures. Therefore, these data suggest that brevenal and gambierol are similar in that they both possess modest affinity for the [3H]PbTx-3-labeled neurotoxin site 5 and that they act as functional antagonists at this site. Interestingly, neither gambierol nor brevenal fit the "binding" motif for neurotoxin site 5 of the VGSC as proposed by Gawley et al. (1995Go). The functional data reported here are consistent with at least one position of the gambierol molecular target coinciding or overlapping with neurotoxin site 5 of the VGSC. Gambierol at a concentration of 0.1 µM recently has been shown to have no influence on the VGSC in taste cells (Ghiaroni et al., 2005Go). Given the Ki value of 1.4 µM for gambierol binding to neurotoxin site 5, a concentration of 0.1 µM may not have produced sufficient fractional occupancy of the VGSC to demonstrate antagonism. Gambierol binding to neurotoxin site 5 may prevent access of brevetoxins to this site; yet, it may have no influence on the VGSC in the absence of brevetoxins. The development of radiolabeled gambierol analogs may facilitate the identification of the precise site(s) of ligand interaction with the VGSC.

In contrast to the lack of effect on mouse taste cell VGSCs, Ghiaroni et al. (2005Go) have shown that gambierol potently inhibited voltage-gated K+ channels in the same cells. Voltage-gated K+ currents evoked by depolarizing pulses were inhibited by gambierol in these cells, with nanomolar potency. The influence of gambierol on IK in taste cells was therefore characterized by an IC50 value (1.8 nM) that is 2 orders of magnitude lower than that determined in the present study for antagonism of site 5 on VGSCs (189 nM). Notwithstanding the potential influence of differing membrane potentials in the two studies, these data indicate that voltage-gated K+ channels may represent the primary molecular target involved in the toxic actions of gambierol. A more recent study using mouse taste cells has demonstrated that ciguatoxin (CTX3C) differs from gambierol in that it did not affect voltage-gated K+ channels (Ghiaroni et al., 2006Go). However, these results indicate that the actions of polyether toxins may differ as a function of cellular context inasmuch as ciguatoxin has been shown to inhibit K+ currents in dorsal root ganglion neurons (Birinyi-Strachan et al., 2005Go).

Gambierol is acutely toxic to mice, and it produces pathological sequelae in the lung and heart (Ito et al., 2003Go). Hypersecretion and ulceration of the stomach also has been identified as a pathological effect of gambierol in mice (Ito et al., 2003Go). These toxic responses may be a consequence of gambierol inhibition of voltage-gated K+ channels.

Although gambierol seems to possess structural components that allow the binding of the toxin to neurotoxin site 5 of the VGSC, this interaction does not seem to result in the activation of the channel, as is the case with brevetoxins and ciguatoxins. Therefore, it is reasonable to infer that gambierol lacks efficacy at neurotoxin site 5 of the VGSC. This investigation has described two measures of functional antagonism of gambierol at neurotoxin site 5 of the VGSC. First, gambierol inhibits brevetoxin-induced elevation of [Ca2+]i in CGN cultures. Second, the well established neurotoxicity of brevetoxins in CGN cultures is also reduced in a concentration-dependent manner by preincubation with gambierol. The gambierol IC50 values reported herein as a functional antagonist of PbTx-2 in CGN cultures are in reasonable agreement with the Ki value for gambierol inhibition of [3H]PbTx-3 binding reported both here and by Inoue et al. (2003Go). Finally, we have also demonstrated that gambierol, like brevenal, although being capable of binding to neurotoxin site 5 of the VGSC, does not elicit a neurotoxic response as is typically observed for activators of this site. As a ligand of the therapeutically relevant VGSC, gambierol may provide a valuable tool in efforts to more clearly define the structure-function relationships of this voltage-sensitive ion channel, and it may provide possible leads for development of novel analgesics, neuroprotectants, and drugs used to treat cystic fibrosis.


    Acknowledgements
 
We thank Dr. Andrea Bourdelais for providing the brevenal sample.


    Footnotes
 
This work was supported in part by National Institutes of Health Grants GM56677 (to J.D.R.) and NS053398 (to T.F.M.).

Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

doi:10.1124/jpet.107.124271.

ABBREVIATIONS: CTX, ciguatoxin; PbTx, brevetoxin; VGSC, voltage-gated sodium channel; CGN, cerebellar granule neuron; DIC, days in culture; LDH, lactate dehydrogenase; CI, confidence interval.

Address correspondence to: Dr. Thomas F. Murray, Department of Pharmacology, Creighton University School of Medicine, Omaha, NE 68178. E-mail: tfmurray{at}creighton.edu


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

Abraham WM, Bourdelais AJ, Sabater JR, Ahmed A, Lee TA, Serebriakov I, and Baden DG (2005) Airway responses to aerosolized brevetoxins in an animal model asthma. Am J Respir Crit Care Med 171: 26–34.[Abstract/Free Full Text]
Baden DG and Adams DJ (2000) Seafood and Freshwater Toxins: Pharmacology, Physiology and Detection (Botana LM ed) pp 505–532, Marcel Dekker, Inc., New York.
Baden DG, Bourdelais AJ, Jacocks H, Michelliza S, and Naar J (2005) Natural and derivative brevetoxins: historical background, multiplicity, and effects. Environ Health Perspect 113: 621–625.[Medline]
Berman FW and Murray TF (1996) Characterization of glutamate toxicity in cultured rat cerebellar granule neurons at reduced temperature. J Biochem Toxicol 11: 111–119.[CrossRef][Medline]
Berman FW and Murray TF (2000) Brevetoxin-induced autocrine excitotoxicity is associated with manifold routes of Ca2+ influx. J Neurochem 74: 1443–1451.[CrossRef][Medline]
Birinyi-Strachan LC, Gunning SJ, Lewis RJ, and Nicholson GM (2005) Block of voltage-gated potassium channels by Pacific ciguatoxin-1 contributes to increased neuronal excitability in rat sensory neurons. Toxicol Appl Pharmacol 204: 175–186.[CrossRef][Medline]
Bourdelais AJ, Campbell S, Jacocks H, Naar J, Wright JL, Carsi J, and Baden DG (2004) Brevenal is a natural inhibitor of brevetoxin action in sodium channel receptor binding assays. Cell Mol Neurobiol 24: 553–563.[CrossRef][Medline]
Bourdelais AJ, Campbell S, Jacocks H, Naar J, Wright JL, Carsi J, and Baden DG (2005) A new polyether ladder compound produced by the dinoflagellate Karina brevis. J Nat Prod 68: 2–6.[CrossRef][Medline]
Cestèle S and Catterall WA (2000) Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie 82: 883–892.[Medline]
Dechraoui MY, Naar J, Pauillac S, and Legrand AM (1999) Ciguatoxins and brevetoxins, neurotoxic polyether compounds active on sodium channels. Toxicon 37: 125–143.[Medline]
Dodd PR, Hardy JA, Oakley AE, Edwardson JA, Perry EK, and Delaunoy JP (1981) A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res 226: 107–118.[CrossRef][Medline]
Fuwa H, Sasaki M, Satake M, and Tachibana K (2002) Total synthesis of gambierol. Org Lett 4: 2981–2984.[CrossRef][Medline]
Fuwa H, Kainuma N, Satake M, and Sasaki M (2003) Synthesis and biological evaluation of gambierol analogues. Bioorg Med Chem Lett 13: 2519–2522.[CrossRef][Medline]
Fuwa H, Kainuma N, Tachibana K, Tsukano C, Satake M, and Sasaki M (2004) Diverted total synthesis and biological evaluation of gambierol analogues: elucidation of crucial structural elements for potent toxicity. Chemistry 10: 4894–4909.[CrossRef][Medline]
Gawley RE, Rein KS, Kinoshita M, and Baden DG (1992) Binding of brevetoxins and ciguatoxin to the voltage-sensitive sodium channel and conformational analysis of brevetoxin B. Toxicon 30: 780–785.[Medline]
Gawley RE, Rein KS, Jeglitsch G, Adams DJ, Theodorakis EA, Tiebes J, Nicolaou KC, and Baden DG (1995) The relationship of brevetoxin "length" and A-ring functionality to binding and activity in neuronal sodium channels. Chem Biol 2: 533–541.[CrossRef][Medline]
Ghiaroni V, Sasaki M, Fuwa H, Rossini GP, Scalera G, Yasumoto T, Pietra P, and Bigiani A (2005) Inhibition of voltage-gated potassium currents by gambierol in mouse taste cells. Toxicol Sci 85: 657–665.[Abstract/Free Full Text]
Ghiaroni V, Fuwa H, Inoue M, Sasaki M, Miyazaki K, Hirama M, Yasumoto T, Rossini GP, Scalera G, and Bigiani A (2006) Effect of ciguatoxin 3C on voltage-gated Na+ and K+ currents in mouse taste cells. Chem Senses 31: 673–680.[Abstract/Free Full Text]
Gordon D (1997) Sodium channels as targets for neurotoxins: mode of action and interaction of neurotoxin with receptor sites on sodium channels, in Toxins and Signal Transduction (Gutman Y and Lazarovici O eds) pp 119–153, Harwood Academic Publishers, New York.
Hogg RC, Lewis RJ, and Adams DJ (1998) Ciguatoxin (CTX-1) modulates single tetrodotoxin-sensitive sodium channels in rat parasympathetic neurones. Neurosci Lett 252: 103–106.[CrossRef][Medline]
Hogg RC, Lewis RJ, and Adams DJ (2002) Ciguatoxin-induced oscillations in membrane potential and action potential firing in rat parasympathetic neurons. Eur J Neurosci 16: 242–248.[CrossRef][Medline]
Inoue M, Hirama M, Satake M, Sugiyama K, and Yasumoto T (2003) Inhibition of brevetoxin binding to the voltage-gated sodium channel by gambierol and gambieric acid-A. Toxicon 41: 469–474.[Medline]
Ito E, Suzuki-Toyota F, Toshimori K, Fuwa H, Tachibana K, Satake M, and Sasaki M (2003) Pathological effects on mice by gambierol, possibly one of the ciguatera toxins. Toxicon 42: 733–740.[Medline]
Jeglitsch G, Rein K, Baden DG, and Adams DJ (1998) Brevetoxin-3 (PbTx-3) and its derivatives modulate single tetrodotoxin-sensitive sodium channels in rat sensory neurons. J Pharmacol Exp Ther 284: 516–525.[Abstract/Free Full Text]
Johnson HW, Majumder U, and Rainier JD (2006) Total synthesis of gambierol: subunit coupling and completion. Chem Eur J 12: 1747–1753.[CrossRef]
Kadota I, Takamura H, Sato K, Ohno A, Matsuda K, Satake M, and Yamamoto Y (2003) Convergent total syntheses of gambierol and 16-epi-gambierol and their biological activities. J Am Chem Soc 125: 11893–11899.[CrossRef][Medline]
Koh JY and Choi DW (1987) Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20: 83–90.[CrossRef][Medline]
LePage KT, Dickey RW, Gerwick WH, Jester EL, and Murray TF (2005) On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies. Crit Rev Neurobiol 17: 27–50.[Medline]
Lewis RJ (2001) The changing face of ciguatera. Toxicon 39: 97–106.[Medline]
Louzao MC, Cagide E, Vieytes MR, Sasaki M, Fuwa H, Yasumoto T, and Botana LM (2006) The sodium channel of human excitable cells is a target for gambierol. Cell Physiol Biochem 17: 257–268.[CrossRef][Medline]
Lowry OH, Rosebrough NJ, Farral AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.[Free Full Text]
Morohashi A, Satake M, and Yasumoto T (1999) The absolute configuration of gambierol, a toxic marine polyether from the dinoflagellate Gambierdiscus toxicus. Tetrahedron Lett 40: 97–100.[CrossRef]
Poli MA, Mende TJ, and Baden DG (1986) Brevetoxins, unique activators of voltage-sensitive sodium channels, bind to specific sites in rat brain synaptosomes. Mol Pharmacol 30: 129–135.[Abstract]
Satake M, Murata M, and Yasumoto M (1993) Gambierol: a new toxic polyether compound isolated from the marine dinoflagellate Gambierdiscus toxicus. J Am Chem Soc 115: 361–362.[CrossRef]
Yasumoto T (2001) The chemistry and biological function of natural marine toxins. Chem Rec 1: 228–242.[CrossRef][Medline]




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Kopljar, A. J. Labro, E. Cuypers, H. W. B. Johnson, J. D. Rainier, J. Tytgat, and D. J. Snyders
A polyether biotoxin binding site on the lipid-exposed face of the pore domain of Kv channels revealed by the marine toxin gambierol
PNAS, June 16, 2009; 106(24): 9896 - 9901.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Cao, J. George, W. H. Gerwick, D. G. Baden, J. D. Rainier, and T. F. Murray
Influence of Lipid-Soluble Gating Modifier Toxins on Sodium Influx in Neocortical Neurons
J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 604 - 613.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.124271v1
323/1/174    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LePage, K. T.
Right arrow Articles by Murray, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LePage, K. T.
Right arrow Articles by Murray, T. F.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition